Gabapentin

Gabapentin is a generic pharmaceutical product used primarily to treat seizures and neuropathic pain. It was originally developed by the pharmaceutical company Parke-Davis, a subsidiary of Warner-Lambert. The drug was first approved for use in the United States in 1993 under the brand name Neurontin. Following the acquisition of Warner-Lambert in 2000, the original brand came under the ownership of Pfizer.

Today, Gabapentin is available as a generic medication and is produced by numerous manufacturers globally, including major pharmaceutical firms such as Teva, Viatris (formerly Mylan), and Sandoz. Manufacturing locations vary significantly depending on the specific supplier, with facilities located in India, the United States, Germany, and China. While Pfizer remains the historical owner of the original brand, the generic drug market is decentralized with no single ultimate owner for the substance itself.